ARCHIVES

FDA Faces Severe Regulatory, Scientific Needs, Report Finds.

This article is from The Cancer Letter archive.

Vol. 34 No. 04 | February 1, 2008

Download PDF Visit The Full Archive

Related Articles

Alimta Reduces Risk Of Progression In Patients Aged 70 Years or Older

October 28, 2011

Cooperative Groups Fight to Keep CGOP Alive As DCPC, DCT Argue Over Who Pays

July 11, 1986

FDA Oncology Unit Fastest in Approvals Despite Having Highest Workload

May 9, 2014

Bass & Howes Bought By DDB Seattle

March 22, 2002

In Congress: Human Genome Project Ahead Of Schedule, Collins Assert

March 27, 1998

Funding opportunities listed.

May 28, 2004